Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Amylin Pharmaceuticals: Will it Navigate the Rough Waters Ahead?
Seeking Alpha
Tuesday, October 26, 2010 - 11:54am
tags:
Amylin, diabetes, exanitide
Bayer rival Boehringer prices blood pill at $6.75
Reuters
Tuesday, October 26, 2010 - 11:52am
tags:
Bayer, Boehringer Ingelheim, drug pricing, anticlotting, JNJ, Pradaxa
Should Investors Take A Chance On Savient?
Investopedia
Tuesday, October 26, 2010 - 11:50am
tags:
Savient, Krystexxa, Bristol-Myers Squibb, Forest Labs, Merck, Novartis, PDI Pharma, Pfizer
GlaxoSmithKline's Dividends May Not Last Forever
Motley Fool
Tuesday, October 26, 2010 - 11:48am
tags:
GSK
Abbott Sues Anchen for Infringing U.S. Patent of Its Zemplar Kidney Drug
Bloomberg
Tuesday, October 26, 2010 - 11:23am
tags:
Abbott Laboratories, patents, Zemplar, Anchen, kidney disease
Bristol-Myers Profit Beats Estimates After Cost Reductions
Bloomberg
Tuesday, October 26, 2010 - 11:21am
tags:
earnings, Bristol-Myers Squibb
Biogen Earnings Beat Street
TheStreet.com
Tuesday, October 26, 2010 - 11:21am
tags:
Biogen Idec, earnings
SuperGen 3Q profit rises on Dacogen royalties
Yahoo/AP
Tuesday, October 26, 2010 - 11:20am
tags:
Supergen, earnings
5 High-Impact Biotech Catalysts to Watch This Week
Seeking Alpha
Tuesday, October 26, 2010 - 11:19am
tags:
Arena Pharmaceuticals, Avanir, Biodel, EXACT Sciences, Vivus
Sanofi-Aventis starts Phase III oral-MS-drug test
Marketwatch
Tuesday, October 26, 2010 - 11:17am
tags:
MS, multiple sclerosis, Sanofi, teriflunomide
Astellas Pharma Falls After Nikkei Report Says Operating Profit Will Slump
Bloomberg
Tuesday, October 26, 2010 - 7:21am
tags:
Astellas
A Good Pharma Pick: Novartis
Seeking Alpha
Tuesday, October 26, 2010 - 7:20am
tags:
Novartis, Alcon, Sanofi
Vertex Quarter Blemished by Hep C Hiccup
TheStreet.com
Tuesday, October 26, 2010 - 7:19am
tags:
Vertex Pharmaceuticals, earnings, hepatitis C, Telaprevir
Amgen Case Shows How to Hide Bad Drug Data and Get Away With It
BNET Pharma
Monday, October 25, 2010 - 8:14pm
tags:
Amgen, Epogen, Aranesp, anemia
Arena Rises After CEO Sees `Path Forward' From Diet Pill's FDA Rejection
Bloomberg
Monday, October 25, 2010 - 8:13pm
tags:
Arena Pharmaceuticals, FDA, Jack Lief
Amarin's Potential Blockbuster in the Making
Seeking Alpha
Monday, October 25, 2010 - 5:50pm
tags:
Amarin, GSK, AMR101
Drugmakers top list of DOJ fraud settlements
Yahoo/AP
Monday, October 25, 2010 - 5:49pm
tags:
DOJ, fraud, Allergan
Amgen Beats Estimates With Shrinking Profit, Sales
Bloomberg
Monday, October 25, 2010 - 5:19pm
tags:
Amgen, earnings
Moms Ask FDA To Rescind Gardasil Approval
Pharmalot
Monday, October 25, 2010 - 5:17pm
tags:
Merck, FDA, vaccines, HPV, Gardasil
Timeline: A look back at Arena's lorcaserin
Fierce Biotech
Monday, October 25, 2010 - 12:35pm
tags:
obesity, Arena Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.